Watchlist Price Alert

Horizon Therapeutics Publ... (HZNP)

NASDAQ: HZNP · Real-Time Price · USD

116.30

0.00 (0.00%)

At close: Jan 16, 2025, 9:00 PM

Horizon Therapeutics Public Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	3.64B	3.58B	3.63B	3.7B	3.81B	3.77B	3.23B	2.96B	2.56B	2.19B	2.2B	1.82B	1.52B	1.38B	1.3B	1.29B	1.28B	1.26B	1.21B	1.13B	1.07B	1.06B	1.06B	1.09B	1.03B	997.29M	981.12M	915.31M	933.15M	848.59M
Cost of Revenue	903.44M	913.7M	920.2M	920.92M	938.43M	909.21M	794.51M	715.29M	615.13M	535.65M	532.7M	465.33M	403.8M	371.45M	362.18M	376.77M	385.84M	396.75M	424.7M	466.68M	493.18M	523.25M	546.27M	544.53M	504.18M	455.15M	393.27M	311.09M	287.18M	267.88M
Gross Profit	2.74B	2.66B	2.71B	2.78B	2.87B	2.86B	2.43B	2.24B	1.94B	1.65B	1.67B	1.35B	1.11B	1B	937.85M	915.25M	896.04M	867.3M	782.87M	659.57M	579.4M	536M	509.96M	547.83M	525.24M	542.13M	587.85M	604.22M	645.97M	580.71M
Operating Income	513.37M	512.87M	671.19M	730.35M	901.29M	897.46M	543.13M	550.11M	447.15M	346.5M	490.03M	304.63M	124.67M	111.92M	126.61M	143.19M	148.81M	125.52M	2K	-146.82M	-226.81M	-414.29M	-392.37M	-446.91M	-442.48M	-225.35M	-147.17M	20.99M	88.04M	23.4M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	443.86M	373.4M	526.94M	583.66M	755.82M	806.67M	462.83M	481.32M	375.84M	263.16M	401.64M	208.98M	-5.11M	-18.06M	-20.22M	-16.37M	20.25M	1.38M	-121.53M	-269.33M	-350.42M	-532.85M	-513.27M	-566.06M	-542.89M	-319.36M	-228.09M	-79.7M	-20.83M	-161.92M
Net Income	438M	371.9M	521.48M	574.26M	764.96M	862.1M	534.49M	551.87M	518.16M	280.04M	389.8M	792.01M	517.4M	592.29M	573.02M	67.81M	75.61M	47.89M	-76.58M	-210.58M	-300.58M	-477.28M	-410.52M	-494.62M	-436.52M	-212M	-166.83M	-12.3M	-3.15M	13.68M
Selling & General & Admin	1.66B	1.62B	1.54B	1.57B	1.53B	1.49B	1.45B	1.32B	1.19B	1.06B	973.23M	881.66M	827.82M	772.59M	697.11M	686.35M	675.61M	685.19M	692.49M	685.28M	677.65M	682.9M	677.36M	710.68M	688.78M	640.43M	608.31M	532.79M	507.23M	508.9M
Research & Development	515.77M	468.98M	437.96M	461.35M	440.84M	477.43M	431.99M	361.96M	298.61M	239.85M	209.36M	167.04M	161.41M	108.65M	103.17M	94.29M	90.89M	86.84M	82.76M	93.95M	90.71M	229.55M	224.96M	218.05M	212.94M	61.05M	60.71M	50.44M	50.69M	48.41M
Other Expenses	404K	-6.17M	-5.57M	-5.73M	-4.3M	-2.17M	1.79M	3.71M	5.28M	6.17M	3.39M	1.04M	1.21M	-691K	-944K	-825K	-1.26M	357K	346K	1.29M	1.11M	732K	589K	138K	6.74M	6.75M	6.7M	6.71M	-262K	-9.31M
Operating Expenses	2.17B	2.09B	1.98B	2.03B	1.97B	1.96B	1.88B	1.69B	1.49B	1.3B	1.18B	1.05B	989.23M	881.24M	800.28M	780.64M	766.5M	772.03M	775.25M	779.23M	768.36M	912.44M	902.33M	928.74M	901.72M	701.48M	669.01M	583.23M	557.92M	557.31M
Interest Expense	68.68M	77.99M	83.71M	87.19M	87.69M	88.86M	81.06M	70.53M	59.74M	55.73M	59.62M	65.2M	73.44M	76.9M	87.09M	99.76M	109.77M	118.77M	121.69M	123.15M	124.42M	124.99M	126.52M	124.16M	111.52M	99.14M	86.61M	77.87M	79.11M	79.33M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	92.67M	165.23M	244.82M	320.37M	291.05M	270.46M	248.93M
Cost & Expenses	3.08B	3B	2.9B	2.95B	2.91B	2.87B	2.67B	2.4B	2.1B	1.83B	1.72B	1.51B	1.39B	1.25B	1.16B	1.16B	1.15B	1.17B	1.2B	1.25B	1.26B	1.44B	1.45B	1.47B	1.41B	1.16B	1.06B	894.32M	845.11M	825.19M
Income Tax Expense	5.86M	1.49M	5.45M	9.41M	-9.14M	-55.44M	-71.66M	-70.55M	-142.32M	-16.88M	11.85M	-583.03M	-522.51M	-610.35M	-593.24M	-84.18M	-55.35M	-46.51M	-44.96M	-58.75M	-49.84M	-55.56M	-102.75M	-71.44M	-106.37M	-107.36M	-61.25M	-67.4M	-17.68M	-175.6M
Shares Outstanding (Basic)	228.74M	228.4M	226.97M	230.33M	230.02M	229.09M	227.04M	226.1M	225.12M	223.92M	220.63M	212.32M	192.71M	190.07M	185.87M	186.47M	185.33M	172.79M	166.57M	167.05M	165.54M	164.55M	164.06M	163.45M	162.93M	161.97M	161.38M	161.04M	160.47M	159.9M
Shares Outstanding (Diluted)	233.94M	233.79M	233.01M	235.39M	236.17M	235.95M	236.95M	236.2M	235.19M	223.92M	235.2M	223.74M	192.71M	190.07M	275.05M	194.17M	185.33M	172.79M	166.57M	172.49M	165.54M	164.55M	164.06M	163.45M	162.93M	161.97M	161.38M	161.04M	163.92M	159.9M
EPS (Basic)	1.92	1.62	2.25	2.48	3.33	3.77	2.35	2.45	2.39	1.27	1.75	4.05	2.77	3.16	3.04	0.40	0.50	0.33	-0.44	-1.24	-1.83	-2.92	-2.52	-3.05	-2.7	-1.32	-1.04	-0.08	-0.02	0.10
EPS (Diluted)	1.87	1.59	2.23	2.44	3.24	3.65	2.23	2.32	2.25	1.16	1.64	3.66	2.44	2.83	2.71	0.37	0.47	0.30	-0.47	-1.25	-1.83	-2.92	-2.52	-3.05	-2.7	-1.32	-1.04	-0.08	-0.02	0.09
EBITDA	957.03M	955.48M	1.11B	1.13B	1.28B	1.27B	909.04M	886.07M	760.71M	644.69M	767.98M	575.4M	324.21M	305.99M	313.58M	320.07M	384.7M	361.48M	283.82M	158.58M	90M	-94.87M	-108.36M	-100.24M	-107.42M	90.08M	147.37M	226.48M	277.91M	161.41M
EBIT	512.54M	505.17M	664.42M	724.63M	897.29M	895.53M	557.35M	565.32M	449.04M	332.35M	461.26M	274.18M	68.33M	58.84M	66.86M	83.39M	130.03M	120.14M	30.61M	-115.73M	-195.55M	-377.4M	-386.75M	-441.91M	-431.38M	-220.22M	-141.47M	-1.83M	58.28M	-82.59M
Depreciation & Amortization	441.47M	442.61M	444.21M	404.88M	383.55M	378.04M	353.75M	326.76M	302.79M	284.53M	279.45M	269.73M	258.54M	244.01M	237.16M	246.5M	256.43M	265.84M	275.86M	276.96M	277.85M	280.84M	283.42M	280.53M	262.33M	242.68M	221.84M	198.78M	190.13M	170.65M